- Home
- BKYI vs SHPH Comparison
BKYI vs SHPH Comparison
Compare BKYI & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- SHPH
- Stock Information
- Founded
- BKYI 1993
- SHPH 2012
- Country
- BKYI United States
- SHPH United States
- Employees
- BKYI N/A
- SHPH N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- SHPH Health Care
- Exchange
- BKYI Nasdaq
- SHPH Nasdaq
- Market Cap
- BKYI 2.7M
- SHPH 2.3M
- IPO Year
- BKYI 1997
- SHPH 2022
- Fundamental
- Price
- BKYI $0.83
- SHPH $0.22
- Analyst Decision
- BKYI
- SHPH
- Analyst Count
- BKYI 0
- SHPH 0
- Target Price
- BKYI N/A
- SHPH N/A
- AVG Volume (30 Days)
- BKYI 222.7K
- SHPH 12.3M
- Earning Date
- BKYI 05-15-2025
- SHPH 05-08-2025
- Dividend Yield
- BKYI N/A
- SHPH N/A
- EPS Growth
- BKYI N/A
- SHPH N/A
- EPS
- BKYI N/A
- SHPH N/A
- Revenue
- BKYI $6,929,571.00
- SHPH N/A
- Revenue This Year
- BKYI $7.45
- SHPH N/A
- Revenue Next Year
- BKYI N/A
- SHPH N/A
- P/E Ratio
- BKYI N/A
- SHPH N/A
- Revenue Growth
- BKYI N/A
- SHPH N/A
- 52 Week Low
- BKYI $0.52
- SHPH $0.23
- 52 Week High
- BKYI $3.68
- SHPH $4.71
- Technical
- Relative Strength Index (RSI)
- BKYI 52.95
- SHPH 33.61
- Support Level
- BKYI $0.74
- SHPH $0.20
- Resistance Level
- BKYI $0.87
- SHPH $0.27
- Average True Range (ATR)
- BKYI 0.08
- SHPH 0.04
- MACD
- BKYI 0.01
- SHPH 0.00
- Stochastic Oscillator
- BKYI 47.08
- SHPH 6.02
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.